ImmunityBio, Inc. IBRX
Set alert
At close · Oct 30
After hours · Oct 30, 7:55 PM ET
- YTD
- +318.69%
- 1 year
- +251.27%
- Open
- 8.48
- Prev close
- 8.74
- Mkt cap
- 8.79B
- Vol
- 8.96M
- Avg vol
- 11.49M
- EPS
- -0.96
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 8.12
- High
- 8.72
- Forward P/E
- -113.05
- Beta
- 0.03
- Short ratio
- 7.96
- Inst. own
- 19.80%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 3, 2026
- 50-d avg
- 8.70
- 200-d avg
- 7.88
- 1y target
- 14.25
5D chart
Signals (109)
| Name | Time | Ago |
|---|---|---|
| SMA: Bullish | Oct 30, 3:20 PM | 1 day ago |
| MACD: Buy Signal | Oct 30, 3:10 PM | 1 day ago |
| SMA: Bullish | Oct 30, 3:05 PM | 1 day ago |
| MACD: Sell Signal | Oct 30, 2:15 PM | 1 day ago |
| SMA: Bearish | Oct 30, 2:10 PM | 1 day ago |
| SMA: Bearish | Oct 30, 2:10 PM | 1 day ago |
| SMA: Bullish | Oct 30, 2:05 PM | 1 day ago |
| SMA: Bullish | Oct 30, 2:05 PM | 1 day ago |
| SMA: Bearish | Oct 30, 2:00 PM | 1 day ago |
| SMA: Bearish | Oct 30, 2:00 PM | 1 day ago |
| SMA: Bullish | Oct 30, 1:55 PM | 1 day ago |
| SMA: Bullish | Oct 30, 1:55 PM | 1 day ago |
| SMA: Bearish | Oct 30, 1:25 PM | 1 day ago |
| SMA: Bullish | Oct 30, 1:10 PM | 1 day ago |
| SMA: Bearish | Oct 30, 12:50 PM | 1 day ago |
| SMA: Bullish | Oct 30, 12:25 PM | 1 day ago |
| SMA: Bullish | Oct 30, 12:15 PM | 1 day ago |
| RSI: Oversold | Oct 30, 12:05 PM | 1 day ago |
| SMA: Bearish | Oct 30, 11:20 AM | 1 day ago |
| MACD: Buy Signal | Oct 30, 10:55 AM | 1 day ago |
| SMA: Bullish | Oct 30, 10:40 AM | 1 day ago |
| RSI: Oversold | Oct 30, 9:45 AM | 1 day ago |
| MACD: Sell Signal | Oct 30, 9:35 AM | 1 day ago |
| SMA: Bearish | Oct 30, 9:30 AM | 1 day ago |
| SMA: Bearish | Oct 30, 9:30 AM | 1 day ago |
| MACD: Buy Signal | Oct 29, 2:45 PM | 2 days ago |
| RSI: Oversold | Oct 29, 2:35 PM | 2 days ago |
| RSI: Oversold | Oct 29, 2:15 PM | 2 days ago |
| SMA: Bearish | Oct 29, 12:30 PM | 2 days ago |
| SMA: Bullish | Oct 29, 12:20 PM | 2 days ago |
| SMA: Bearish | Oct 29, 12:00 PM | 2 days ago |
| SMA: Bullish | Oct 29, 11:55 AM | 2 days ago |
| SMA: Bearish | Oct 29, 11:40 AM | 2 days ago |
| SMA: Bullish | Oct 29, 11:20 AM | 2 days ago |
| SMA: Bearish | Oct 29, 10:55 AM | 2 days ago |
| SMA: Bearish | Oct 29, 10:45 AM | 2 days ago |
| SMA: Bullish | Oct 29, 10:20 AM | 2 days ago |
| MACD: Sell Signal | Oct 29, 10:10 AM | 2 days ago |
| SMA: Bearish | Oct 29, 10:05 AM | 2 days ago |
| RSI: Overbought | Oct 29, 10:00 AM | 2 days ago |
| RSI: Overbought | Oct 29, 9:50 AM | 2 days ago |
| RSI: Overbought | Oct 28, 3:55 PM | 3 days ago |
| SMA: Bullish | Oct 28, 3:30 PM | 3 days ago |
| SMA: Bullish | Oct 28, 3:30 PM | 3 days ago |
| MACD: Buy Signal | Oct 28, 3:30 PM | 3 days ago |
| MACD: Sell Signal | Oct 28, 3:15 PM | 3 days ago |
| SMA: Bearish | Oct 28, 3:10 PM | 3 days ago |
| SMA: Bullish | Oct 28, 2:30 PM | 3 days ago |
| SMA: Bullish | Oct 28, 2:25 PM | 3 days ago |
| MACD: Buy Signal | Oct 28, 2:25 PM | 3 days ago |
| SMA: Bearish | Oct 28, 1:35 PM | 3 days ago |
| SMA: Bullish | Oct 28, 1:30 PM | 3 days ago |
| SMA: Bearish | Oct 28, 12:55 PM | 3 days ago |
| SMA: Bullish | Oct 28, 12:50 PM | 3 days ago |
| SMA: Bullish | Oct 28, 12:30 PM | 3 days ago |
| SMA: Bullish | Oct 28, 12:30 PM | 3 days ago |
| MACD: Sell Signal | Oct 28, 11:50 AM | 3 days ago |
| SMA: Bearish | Oct 28, 11:40 AM | 3 days ago |
| SMA: Bullish | Oct 28, 10:45 AM | 3 days ago |
| MACD: Buy Signal | Oct 28, 10:45 AM | 3 days ago |
| SMA: Bearish | Oct 28, 10:15 AM | 3 days ago |
| SMA: Bearish | Oct 28, 10:15 AM | 3 days ago |
| SMA: Bullish | Oct 28, 10:10 AM | 3 days ago |
| SMA: Bullish | Oct 28, 10:10 AM | 3 days ago |
| SMA: Bearish | Oct 28, 10:00 AM | 3 days ago |
| SMA: Bearish | Oct 28, 10:00 AM | 3 days ago |
| SMA: Bullish | Oct 28, 9:55 AM | 3 days ago |
| SMA: Bullish | Oct 28, 9:55 AM | 3 days ago |
| SMA: Bullish | Oct 28, 9:35 AM | 3 days ago |
| SMA: Bearish | Oct 28, 9:30 AM | 3 days ago |
| SMA: Bearish | Oct 28, 9:30 AM | 3 days ago |
| SMA: Bullish | Oct 27, 3:55 PM | 4 days ago |
| SMA: Bearish | Oct 27, 3:45 PM | 4 days ago |
| MACD: Sell Signal | Oct 27, 3:45 PM | 4 days ago |
| MACD: Buy Signal | Oct 27, 3:35 PM | 4 days ago |
| SMA: Bullish | Oct 27, 2:50 PM | 4 days ago |
| SMA: Bearish | Oct 27, 2:45 PM | 4 days ago |
| SMA: Bullish | Oct 27, 1:25 PM | 4 days ago |
| SMA: Bearish | Oct 27, 1:10 PM | 4 days ago |
| SMA: Bullish | Oct 27, 1:05 PM | 4 days ago |
| MACD: Sell Signal | Oct 27, 12:15 PM | 4 days ago |
| MACD: Buy Signal | Oct 27, 12:10 PM | 4 days ago |
| MACD: Sell Signal | Oct 27, 11:55 AM | 4 days ago |
| MACD: Buy Signal | Oct 27, 11:40 AM | 4 days ago |
| RSI: Overbought | Oct 27, 11:35 AM | 4 days ago |
| MACD: Sell Signal | Oct 27, 11:20 AM | 4 days ago |
| RSI: Overbought | Oct 27, 11:20 AM | 4 days ago |
| RSI: Overbought | Oct 27, 10:35 AM | 4 days ago |
| RSI: Overbought | Oct 27, 10:20 AM | 4 days ago |
| RSI: Overbought | Oct 27, 10:05 AM | 4 days ago |
| RSI: Overbought | Oct 27, 9:50 AM | 4 days ago |
| RSI: Overbought | Oct 27, 9:35 AM | 4 days ago |
| SMA: Bullish | Oct 26, 3:55 PM | 5 days ago |
| MACD: Buy Signal | Oct 26, 3:35 PM | 5 days ago |
| SMA: Bullish | Oct 26, 3:30 PM | 5 days ago |
| MACD: Sell Signal | Oct 26, 2:40 PM | 5 days ago |
| SMA: Bearish | Oct 26, 2:20 PM | 5 days ago |
| SMA: Bullish | Oct 26, 2:00 PM | 5 days ago |
| SMA: Bearish | Oct 26, 1:55 PM | 5 days ago |
| SMA: Bearish | Oct 26, 1:55 PM | 5 days ago |
| SMA: Bullish | Oct 26, 1:50 PM | 5 days ago |
| SMA: Bullish | Oct 26, 1:10 PM | 5 days ago |
| SMA: Bearish | Oct 26, 12:40 PM | 5 days ago |
| SMA: Bullish | Oct 26, 12:35 PM | 5 days ago |
| SMA: Bearish | Oct 26, 11:55 AM | 5 days ago |
| SMA: Bullish | Oct 26, 11:10 AM | 5 days ago |
| RSI: Oversold | Oct 26, 11:05 AM | 5 days ago |
| SMA: Bearish | Oct 26, 10:30 AM | 5 days ago |
| SMA: Bullish | Oct 26, 10:25 AM | 5 days ago |
News
4 days ago benzinga.com
Jim Cramer Calls Celsius 'A Second-Rate Monster,' Says Stick With the Original
Jim Cramer called ImmunityBio a strong speculative buy, favored Monster over Celsius, avoided USA Rare Earth and liked Glacier Bancorp.
5 days ago defenseworld.net
ImmunityBio, Inc. $IBRX Stake Trimmed by Davidson Kahn Capital Management LLC
Davidson Kahn Capital Management LLC lessened its stake in ImmunityBio, Inc. (NASDAQ: IBRX) by 50.9% during the third quarter, according to its most recent filing with the Securities and Exchange…
-
1 week ago benzinga.com
ImmunityBio Anticipates Reporting Topline Results In November 2026, Remains On Track To Submit sBLA To FDA In Q4 2026 For ANKTIVA Plus BCG In Patients With BCG-Naïve NMIBC
Database lock completed for Cohort A of QUILT-2.005 (NCT02138734), a randomized, controlled registrational trial comparing ANKTIVA® plus BCG with BCG alone in 366 patients with BCG-naïve non-muscle…
-
1 week ago benzinga.com
ImmunityBio Completes Database Lock For Cohort A Of QUILT-2.005, Randomized, Controlled, Registrational Trial Evaluating ANKTIVA In Combination With BCG Versus BCG Alone In Patients With BCG-Naïve NMIBC
Database lock completed for Cohort A of QUILT-2.005 (NCT02138734), a randomized, controlled registrational trial comparing ANKTIVA® plus BCG with BCG alone in 366 patients with BCG-naïve non-muscle…
1 week ago benzinga.com
9 Health Care Stocks Whale Activity In Today’s Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity…
1 week ago benzinga.com
ImmunityBio Study Shows Long-Term Success for Bladder Cancer Treatment
New data show ImmunityBio's ANKTIVA combined with BCG provides durable responses and high survival rates in unresponsive bladder cancer.
-
2 weeks ago benzinga.com
ImmunityBio Announces Data From Its Phase 2/3 QUILT-3.032 Trial Of ANKTIVA In Combination With Bacillus Calmette-Guerin Demonstrates 71% Complete Response Rate In Participants With BCG-Unresponsive Non-Muscle Invasive Bladder Cancer With Carcinoma In Situ
ImmunityBio, Inc. ((IBRX), a commercial-stage immunotherapy company, today announced the publication of long-term data from the Phase 2/3 QUILT-3.032 study (N=100) in the Journal of Urology. The…
-
2 weeks ago benzinga.com
Jefferies Maintains Buy on ImmunityBio, Raises Price Target to $14
Jefferies analyst Kelly Shi maintains ImmunityBio (NASDAQ:IBRX) with a Buy and raises the price target from $12 to $14.
2 weeks ago benzinga.com
ImmunityBio Stock Climbs Thursday: What's Going On?
ImmunityBio shares are trading higher Thursday after the FDA approved expansion for its bladder cancer therapy ANKTIVA.
-
2 weeks ago benzinga.com
HC Wainwright & Co. Reiterates Buy on ImmunityBio, Maintains $15 Price Target
HC Wainwright & Co. analyst Andres Y. Maldonado reiterates ImmunityBio (NASDAQ:IBRX) with a Buy and maintains $15 price target.
2 weeks ago benzinga.com
Why Is ImmunityBio Stock Gaining Wednesday?
ImmunityBio (IBRX) stock jumps over 5% following FDA expanded approval for Anktiva in NMIBC bladder cancer treatment. Get details.
3 weeks ago benzinga.com
10 Health Care Stocks Whale Activity In Today’s Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity…
3 weeks ago benzinga.com
Humana, Evolution Metals & Technologies, Fastly And Other Big Stocks Moving Higher On Friday
U.S. stocks rose Friday; Humana jumped 12.3% after improved 2027 Medicare Advantage ratings and reaffirmed FY26 EPS guidance.
4 weeks ago benzinga.com
ImmunityBio Stock Jumps: What's Going On?
ImmunityBio Inc. (NASDAQ: IBRX) shares are soaring Friday, extending a steadily rising pattern that's played out over the past several months.